Boulet Lysiane, Faure Patrice, Flore Patrice, Montérémal Julien, Ducros Véronique
Department of Biochemistry, Toxicology and Pharmacology, Grenoble Alpes University Hospital, Grenoble, France; Research Unit INSERM U1042, HP2 Laboratory, Grenoble, France; Univ. Grenoble Alpes, Grenoble, France.
Department of Biochemistry, Toxicology and Pharmacology, Grenoble Alpes University Hospital, Grenoble, France; Research Unit INSERM U1042, HP2 Laboratory, Grenoble, France; Univ. Grenoble Alpes, Grenoble, France.
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Jun 1;1054:36-43. doi: 10.1016/j.jchromb.2017.04.010. Epub 2017 Apr 4.
Tryptophan (Trp) is an essential amino-acid and the precursor of many biologically active substances such as kynurenine (KYN) and serotonin (5HT). Its metabolism is involved in different physiopathological states, such as cardiovascular diseases, cancer, immunomodulation or depression. Hence, the quantification of Trp catabolites, from both KYN and 5HT pathways, might be usefulfor the discovery of novel diagnostic and follow-up biomarkers. We have developed a simple method for quantification of Trp and 8 of its metabolites,involved in both KYN and 5HT pathways, using liquid chromatography coupled to tandem mass spectrometry. We also validated the methodin human plasma samples, according to NF EN ISO 15189 criteria. Our method shows acceptable intra- and inter-day coefficients of variation (CV) (<12% and <16% respectively). The linearity entirelycovers the human plasma range. Stabilities of whole blood and of residues weredetermined, as well as the use of 2 different types of collectiontube, enabling us to adapt our process. Matrix effects and reference values showed good agreement compared to the literature. We propose here a method allowing the simultaneous quantification of a panel of Trp catabolites, never used before to our knowledge. This method, witha quickchromatographic runtime (15min) and simple sample preparation, has beenvalidated according to NF EN ISO 15189 criteria. The method enables the detailed analysis of these metabolic pathways, which are thought to be involved in a number of pathological conditions.
色氨酸(Trp)是一种必需氨基酸,也是许多生物活性物质的前体,如犬尿氨酸(KYN)和血清素(5HT)。其代谢参与不同的生理病理状态,如心血管疾病、癌症、免疫调节或抑郁症。因此,对KYN和5HT途径中色氨酸分解代谢产物的定量,可能有助于发现新的诊断和随访生物标志物。我们开发了一种简单的方法,使用液相色谱-串联质谱联用技术,对参与KYN和5HT途径的色氨酸及其8种代谢产物进行定量。我们还根据NF EN ISO 15189标准在人类血浆样本中验证了该方法。我们的方法显示出可接受的日内和日间变异系数(CV)(分别<12%和<16%)。线性范围完全覆盖人类血浆范围。我们测定了全血和残留物的稳定性,以及两种不同类型采集管的使用情况,使我们能够调整我们的流程。与文献相比,基质效应和参考值显示出良好的一致性。我们在此提出一种方法,能够同时定量一组色氨酸分解代谢产物,据我们所知,这是以前从未使用过的。该方法具有快速的色谱运行时间(15分钟)和简单的样品制备过程,并已根据NF EN ISO 15189标准进行了验证。该方法能够对这些被认为与多种病理状况有关的代谢途径进行详细分析。